Sign in
Taking peopleNo phase

MinION gene reading tool to find germs in diabetic foot bone infection

Compares MinION with routine lab culture for finding germs in diabetic foot bone infection.

Key facts

Who runs it
Centre Hospitalier Universitaire de Nīmes
Where
France1 site in 1 countryChoose a country to see its sites
Trial code
Registry title
New Diagnostic Tool (MinION) for Identifying Microorganisms in Foot Wounds of Patients Living With Diabetic Foot Osteomyelitis
Status
Recruiting
People taking part
43 people, planned
Started
12 Feb 2026
Expected to end
Dec 2027
Type of study
Observational
Record updated
13 November 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for people with diabetes who have a bone infection in the foot (diabetic foot osteomyelitis). It compares a new test (MinION) with routine lab culture on bone samples.

Sex
All sexes can join.
Disease stage
Diabetic foot osteomyelitis, a bone infection under a foot wound.

The registry criteria, word for word

Show all 2 criteriaShow less

Who can take part

  • N/A

Who cannot take part

  • N/A

This trial is currently available in France.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Diabetic foot wound infections are predominantly polymicrobial. However, 'conventional' microbiological culture does not identify all the bacteria potentially involved in these infections and requires time, which can have a negative impact by delaying treatment and/or the prescription of appropriate antibiotic therapy.

Read full original descriptionShow less

Real-time metagenomics analysis using Oxford Nanopore Technologies' MinION technology has demonstrated sufficient power to identify virtually all microbial genomes in a given sample, providing additional information on their antibiotic resistance profile and in silico prediction of genes encoding virulence factors within than 4 hours. Based on these rapid results, a management protocol could be defined specifically for each patient with a view to personalised medicine.

The aim is to study the diversity of bacterial and fungal species identified using the MinION method and compare this diversity with the results obtained using conventional methods (routine culture) from bone biopsies taken from DFOM patients.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Evaluation of a New Diagnostic Tool (MinION) for Identifying Microorganisms in the Foot Wounds of Patients Living With Diabetic Foot Osteomyelitis (DFOM)
Plain-language title
MinION gene reading tool to find germs in diabetic foot bone infectionGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 15 November 2026.
Record updated
13 November 2026